Skip to content

Non-drug therapy for treating patients with severe COVID-19 infection: a multicenter randomized controlled trial

Non-drug therapy for treating patients with severe COVID-19 infection: a multicenter randomized controlled trial

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068319
Enrollment
Unknown
Registered
2023-02-15
Start date
2023-02-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 infection

Interventions

Treatment group:Non-drug therapy and symptomatic treatment
Control group:Symptomatic treatment

Sponsors

Shanghai Municipal Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Age between 18 and 90; (2) Meet the diagnostic criteria of severe severity of the diagnosis and treatment protocol for COVID-19 infection (Trial version 10); meets any of the following criteria that cannot be explained by anything other than COVID-19 infection: 1) shortness of breath, respiratory rates>30 times/min,; 2) finger oxygen saturation during air inhalation>93%; 3) Arterial partial oxygen pressure/oxygen absorption concentration50% within 24-48 hours. (3) Agree to participate in the trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Mild, moderate or critically ill patients infected with the COVID-19; (2) Women in late pregnancy or perinatal period; (3) With consciousness disorder, mental disorder, language disorder, etc., loss of self-care ability, unable to communicate normally, or unable to cooperate with treatment; (4) With immune deficiency (HIV, etc.), severe pulmonary embolism, severe liver and kidney failure, severe coagulation dysfunction, encephalitis, or cirrhosis, etc.; (5) History of severe drug and food allergies; (6) Large area of broken back skin.

Design outcomes

Primary

MeasureTime frame
improvement rate of finger oxygen saturation;respiratory rate;

Secondary

MeasureTime frame
respiratory symptoms;inpatient days;prognosis of disease;types of oxygen therapy;adverse events;

Countries

China

Contacts

Public ContactShifen Xu

Shanghai Municipal Hospital of Traditional Chinese Medicine

xu_teacher2006@126.com13761931393

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026